Pozen, Inc. (NQ: POZN)
8.700 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(POZN) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 18, 2014
(, 3/25/12)
This morning, Pozen (POZN) announced positive results from the company's two pivotal phase 3 clinical trials studying PA32540, a novel, coordinated-delivery tablet of immediate-release omeprazole (40mg)...(read more)
(Samurai Trader, 4/6/12)
Despite a relatively weak market, the leadership list actually had a pretty good week. There were about an equal number of gainers and decliners, but the gains far outweighed the losses. POZN was the biggest gainer, with...(read more)
(tickerspy.com, 6/2/10)
Shares of POZEN (POZN) are higher today after analyst Brean Murray suggested that Pozen has become an even more attractive acquisition target following the firm's receipt of a $20 million milestone payment from AstraZeneca (AZN)...(read more)
Pozen (POZN) Company Overview

There is no analysis for POZN yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here